search
Back to results

The Impact of Dietary Pattern on Erectile Function (ERECTION)

Primary Purpose

Erectile Dysfunction

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Animal based diet
Plant based diet
Sponsored by
Montefiore Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Erectile Dysfunction focused on measuring Diet, Erectile function, Plant-based, Animal-based

Eligibility Criteria

18 Years - 35 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Subject provides written informed consent and HIPAA authorization in English before any study procedures are conducted;
  • No medical therapy (other than prn MDIs (metered dose inhalers) & no change in supplements if applicable)
  • IIEF score greater or equal to 22
  • Subject will have had penile-vaginal sex within 4 weeks of enrollment. The IIEF score utilized is validated based on this time window.
  • Male aged 18-29 years old
  • Lives within commuting distance of Montefiore Health System
  • Subject's significant other (if applicable) agrees to support the subject during the study
  • Subject agrees to photograph and share all items consumed/drunk during the dietary intervention
  • Subject agrees to avoid all illicit drugs, NSAIDs, and alcohol for at least two days prior to Rigiscan™ recording and on the days and nights of Rigiscan™ recording
  • Subject agrees to refrain from sexual activity for at least 36 hours prior to Rigiscan™ placement and to have no sexual activity on the days and nights of Rigiscan™ recording.
  • Subject agrees to not view, read, or otherwise consume erotic or pornographic material for at least 36 hours prior to the days and nights of Rigiscan™ recording and on the days and nights of Rigiscan™ recording
  • Subject agrees to come to Montefiore to undergo Rigiscan™ training
  • Subject agrees to only consume/drink permitted food/beverages.
  • Subject agrees to attend all in person visits at Montefiore, to begin fasting at 11pm the night before each visit, and to undergo all blood draws/salivary/other testing.
  • Subject agrees to not use mouthwash or mouth rinses or intentionally spit for the entire duration of the study. Subjects will be asked to refrain from using mouthwash for at least 2 days prior to enrollment. Subject agrees to not brush his teeth in the morning of the day of each study visit. Tooth brushing is otherwise permissible.
  • BMI Less than 30, BMI greater or equal to 18.5, weight greater than 110 lbs.
  • Subject agrees to comply with the study procedures and visits.
  • Subject exercises for at least 15 minutes at least two times per week. Subject agrees to avoid exercise the day before and the day of Rigiscan™ measurements

Exclusion Criteria:

  • Relevant dietary allergy
  • Vegetarian or Vegan dietary pattern
  • History of an eating disorder; evidence of food addiction
  • Hypertension and or history of hypertension with or without medical treatment
  • BMI greater or equal to 30, BMI less than 18.5, or weight less than or equal to 110lbs
  • Known chronic medical disease other than non-inflammatory musculoskeletal disease and asthma
  • History of kidney disease or hyperkalemia
  • Subject has received an investigational drug within 30 days prior to signing consent
  • Erectile dysfunction
  • Has any condition (e.g., psychiatric illness) or situation that, in the investigator's opinion, may confound the study results, or may interfere significantly with the patient's ability to adhere with study procedures
  • Currently undergoing treatment for Peyronie's Disease
  • Abnormal Testosterone or Thyroid Stimulating Hormone level
  • Treated hypogonadism or hypothyroidism
  • Planned travel during the study
  • History of substance abuse in the last 12 months
  • Illicit drug use, smoking, or vaping within 4 weeks
  • Upper respiratory illness within two weeks on screening
  • If profession requires being on call, no overnight or on call duties during the study
  • Any communicable skin or venereal disease. Subject reports rash or lesions on the penis or surrounding area. Subject will be asked, "do you have a rash or lesion on your penis or surrounding area?"

Sites / Locations

  • Montefiore Medical Center, Department of Medicine, Division of CardiologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Plant-based arm

Animal-based arm

Arm Description

The plant-based arm consists of 3 visits to the clinical research center, following a plant-based diet and using the Rigiscan™ device to measure the frequency, rigidity, and duration of nocturnal erections.

The animal-based arm consists of 3 visits to the clinical research center, following an animal- based diet and using the Rigiscan™ device to measure the frequency, rigidity, and duration of nocturnal erections.

Outcomes

Primary Outcome Measures

Percent of time ≥70% erect during overnight sleep after 4 meals.
Total time (in minutes) when penile rigidity is ≥ 70% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).

Secondary Outcome Measures

Percent of time ≥70% erect during overnight sleep after 1 meal.
Total time (in minutes) when penile rigidity is ≥70% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).
Erection events per hour during overnight sleep after 4 meals.
Total number of erection events lasting ≥5 minutes and with ≥70% rigidity at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™). This result will be reported as Events/hour.
Tumescence events per hour during overnight sleep after 4 meals.
Total number of tumescence events lasting ≥5 minutes and when penile circumference increases by ≥2cm at both the tip and the base of the penis compared to their respective baselines as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™). This result will be reported as Tumescence events/hour

Full Information

First Posted
March 27, 2020
Last Updated
October 17, 2023
Sponsor
Montefiore Medical Center
Collaborators
The Purjes Foundation, The Greenbaum Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT04349059
Brief Title
The Impact of Dietary Pattern on Erectile Function
Acronym
ERECTION
Official Title
The Impact of a Plant-Based Diet Versus an Animal-Based Diet on Erectile Function in Healthy Men With Normal Erectile Function: The ERECTION Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 2, 2023 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Montefiore Medical Center
Collaborators
The Purjes Foundation, The Greenbaum Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to determine whether erectile function is impacted by dietary patterns in healthy men with normal erectile function.
Detailed Description
Visit 1: After reviewing and signing consent, subjects will be screened for the study. Screening will consist of the following: Complete International Index of Erectile Function (IIEF) questionnaire. Record medical history, concomitant medications Measure height and weight, calculate BMI Vitals Draw blood for total testosterone, sex hormone binding globulin and Thyroid Stimulating Hormone Query subject regarding the presence of genital rash or lesions. Subjects will be asked, "do you have a rash or lesion on your penis or surrounding area?" If the IIEF score is abnormal, subjects will be advised to contact their primary care provider. Each subject will be contacted by phone with their blood results. If abnormal subject will be given the recommendation to contact his primary care provider. If an abnormal finding is identified during screening, such as an abnormal STOP-bang score, subject will be given the recommendation to contact his primary care provider. If the subject has no primary care provider, contact information for primary care will be given. Subjects meeting inclusion and exclusion criteria will be randomized into the study, into either Sequence One or Sequence Two. Once enrolled, subjects will be asked to not modify their dietary habits throughout the duration of the study other than during the two evenings and two full days when food is provided (see below). Sequence One: Visit 2: Subjects will return to the study center in the morning after having fasted (other than consuming water) since 11pm the night before. They will have been asked to not brush their teeth or use mouthwash and/or other breath fresheners that morning. Anthropomorphic and blood pressure and heart rate recordings will be made. Saliva will be stored for NO measurement. Blood will be drawn and stored. Urine will be collected and stored. Subjects will be taught how to use the Rigiscan™ device. Subjects will receive one plant-based dinner (food will be provided by Montefiore-Einstein Food Services.) Subjects will then leave the study center and they will consume their usual diet until 5pm. For the rest of the evening until 11pm they will consume only the dinner provided. Water will be the only beverage allowed after 5pm. Dinner should be consumed at 8:30pm EST. Subjects will text pictures of everything they consume (eat or drink) after 5pm to Dr. Ostfeld or to a study representative and s/he will have text or verbal contact with the subject at least once that evening. That night, subjects will do a Rigiscan™ assessment overnight at their home. The time the subject goes to bed and the time the subject wakes up for the day should be recorded. The subject agrees to be in bed with Rigiscan™ on (other than for emergency or needed trips to the bathroom) for at least seven hours. Visit 3 Subjects will return to the study center the morning after the Rigiscan™ assessment and bring the Rigiscan™ device with them. They will have been fasting other than drinking water since 11pm the night before. They will have been asked to not brush their teeth or use mouthwash and/or other breath fresheners that morning. Anthropomorphic and blood pressure and heart rate recordings will be taken. Saliva will be stored for NO measurement. Blood will be drawn and stored. Urine will be collected and stored. Subjects will then receive one full day of plant-based meals (food will be provided by Montefiore-Einstein Food Services.) Subjects will be encouraged to eat breakfast at the study center after the initial anthropomorphic measures are made, saliva is obtained, and blood is drawn. Subjects will text pictures of all they consume during that day to Dr. Ostfeld and/or to a study representative and s/he will have text or verbal contact with the subject at least twice during that day. Dinner should be consumed at 8:30pm, EST. Subjects will fast other than water after 11pm. That night, subjects will do a Rigiscan™ assessment overnight at their home. Black coffee and/or tea is permitted only before noon. The time the subject goes to bed and the time the subject wakes up for the day should be recorded. The subject agrees to be in bed with Rigiscan™ on (other than for emergency or needed trips to the bathroom) for at least seven hours. Visit 4 Subjects will return to the study center the morning after the Rigiscan™ assessment and bring the Rigiscan™ device with them. They will have been asked to not brush their teeth or use mouthwash and/or other breath fresheners that morning. Anthropomorphic and blood pressure and heart rate recordings will be taken. Saliva will be stored for NO measurement. Blood will be drawn and stored. Urine will be collected and stored. There will then be a washout period for 8-12 days and subjects will be instructed to return to their usual dietary habits during this washout period. Number of days of the washout period will be recorded. Visit 5 After the washout period, subjects will return to the study center in the morning after having fasted (other than consuming water) since 11pm the night before. They will have been asked to not brush their teeth or use mouthwash and/or other breath fresheners that morning. Anthropomorphic and blood pressure and heart rate recordings will be taken. Saliva will be stored for NO measurement. Blood will be drawn and stored. Urine will be collected and stored. Subjects will receive one animal-based dinner (food will be provided by Montefiore-Einstein Food Services.) Subjects will then leave the study center and they will consume their usual diet until 5pm. For the rest of the evening until 11pm they will consume only the dinner provided. Water will be the only beverage consumed after 5pm. Dinner should be consumed at 8:30pm, EST. Subjects will text pictures of all they consume (eat or drink) after 5pm to Dr. Ostfeld or to a study representative and s/he will have text or verbal contact with the subject at least once that evening. Subjects will fast other than water after 11pm. That night, subjects will do a Rigiscan™ assessment overnight at their home. The time the subject goes to bed and the time the subject wakes up for the day should be recorded. The subject agrees to be in bed with Rigiscan™ on (other than for emergency or needed trips to the bathroom) for at least seven hours. Visit 6 Subjects will return to the study center the morning after the Rigiscan™ assessment and bring the Rigiscan™ device with them. They will have been asked to not brush their teeth or use mouthwash and/or other breath fresheners that morning. Anthropomorphic and blood pressure and heart rate recordings will be taken. Saliva will be stored for NO measurement. Blood will be drawn and stored. Urine will be collected and stored. Subjects will then receive one full day of animal-based meals (food will be provided by Montefiore-Einstein Food Services.) Subjects will be encouraged to eat breakfast at the study center after the initial anthropomorphic measures are made, saliva is obtained, and blood is drawn. Subjects will text pictures of all they consume during that day to Dr. Ostfeld and/or to a study representative and s/he will have text or verbal contact with the subject at least twice during that day. Dinner should be consumed at 8:30pm, EST. Subjects will fast other than water after 11pm. That night, subjects will do a Rigiscan™ assessment overnight at their home. Black coffee and/or tea is permitted only before noon. The time the subject goes to bed and the time the subject wakes up for the day should be recorded. The subject agrees to be in bed with Rigiscan™ on (other than for emergency or needed trips to the bathroom) for at least seven hours. Visit 7 (End of Study) Subjects will return to the study center the morning after the Rigiscan™ assessment and bring the Rigiscan™ device with them. They will have been asked to not brush their teeth or use mouthwash and/or other breath fresheners that morning. Anthropomorphic and blood pressure and heart rate recordings will be taken. Saliva will be stored for NO measurement. Blood will be drawn and stored. Urine will be collected and stored. Sequence Two: Sequence Two is identical to Sequence One, except that the order of the plant-based and animal-based meals is reversed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Erectile Dysfunction
Keywords
Diet, Erectile function, Plant-based, Animal-based

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Randomized crossover design
Masking
Outcomes Assessor
Masking Description
Outcomes assessor will be blinded to randomization group and order of testing.
Allocation
Randomized
Enrollment
46 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Plant-based arm
Arm Type
Active Comparator
Arm Description
The plant-based arm consists of 3 visits to the clinical research center, following a plant-based diet and using the Rigiscan™ device to measure the frequency, rigidity, and duration of nocturnal erections.
Arm Title
Animal-based arm
Arm Type
Active Comparator
Arm Description
The animal-based arm consists of 3 visits to the clinical research center, following an animal- based diet and using the Rigiscan™ device to measure the frequency, rigidity, and duration of nocturnal erections.
Intervention Type
Other
Intervention Name(s)
Animal based diet
Intervention Description
Food will be provided by Montefiore-Einstein Food Services
Intervention Type
Other
Intervention Name(s)
Plant based diet
Intervention Description
Food will be provided by Montefiore-Einstein Food Services
Primary Outcome Measure Information:
Title
Percent of time ≥70% erect during overnight sleep after 4 meals.
Description
Total time (in minutes) when penile rigidity is ≥ 70% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).
Time Frame
During overnight sleep directly after consuming the 4 meals.
Secondary Outcome Measure Information:
Title
Percent of time ≥70% erect during overnight sleep after 1 meal.
Description
Total time (in minutes) when penile rigidity is ≥70% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).
Time Frame
During overnight sleep directly after consuming the 1 meal.
Title
Erection events per hour during overnight sleep after 4 meals.
Description
Total number of erection events lasting ≥5 minutes and with ≥70% rigidity at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™). This result will be reported as Events/hour.
Time Frame
During overnight sleep directly after consuming the 4 meals.
Title
Tumescence events per hour during overnight sleep after 4 meals.
Description
Total number of tumescence events lasting ≥5 minutes and when penile circumference increases by ≥2cm at both the tip and the base of the penis compared to their respective baselines as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™). This result will be reported as Tumescence events/hour
Time Frame
During overnight sleep directly after consuming the 4 meals.
Other Pre-specified Outcome Measures:
Title
Heart rate
Description
Comparing heart rate by dietary pattern at both time points (after overnight sleep after consuming the 1 meal and after overnight sleep after consuming the 4 meals) and compared to its respective baseline in beats/minute. Definition: In regard to the following anthropometric, vital sign, and laboratory data (blood, urine, and saliva) pre-specified outcomes included in this pre-specified outcomes section, at "both time points" is defined as in the sentence above and "respective baseline" refers to either visit 2 or visit 5, as visit 2 is the baseline for one dietary arm (plant or animal) and visit 5 is the baseline for the other dietary arm (plant or animal).
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Blood Pressure
Description
Comparing blood pressure by dietary pattern at both time points and compared to its respective baseline in mmHg
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Weight
Description
Comparing weight by dietary pattern at both time points and compared to its respective baseline
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Fibrinogen
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
D-dimer
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in ng/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Total cholesterol
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
HDL cholesterol
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
HDL efflux capacity
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline.
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
LDL cholesterol
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Triglyceride
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Oxidized LDL cholesterol
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in U/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Free Fatty Acids
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in micromoles
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Myeloperoxidase
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in ug/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Factor VII
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in percentage.
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
lysolecithin
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Apolipoprotein B
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Omega 3 index
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in percentage of erythrocyte fatty acid
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Lipoprotein-associated phospholipase-A2 (Lp PLA2) activity
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in nmol/min/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Lipoprotein (a)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in nmol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Homocysteine
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in umol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
methylmalonic acid (MMA)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in umol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Asymmetric Dimethylarginine (ADMA)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in umol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
symmetric dimethylarginine (SDMA)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Total testosterone
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Sex Hormone Binding Globulin
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in nmol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
cystatin C
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
remnant cholesterol particles
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
uric acid
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
interleukin 1
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in pg/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
interleukin 6
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in pg/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
hsCRP
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Blood Urea Nitrogen (BUN)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Carbon Dioxide (CO2)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mmol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
creatinine
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
glucose
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
serum chloride
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in meq/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
serum potassium
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in meq/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
serum sodium
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in meq/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
alanine aminotransferase (ALT)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in units/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
aspartate aminotransferase (AST)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in units/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
estimated glomerular filtration rate (eGFR)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mL/min/1.73m2
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
vitamin c
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/dL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
reduced glutathione
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in umol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
superoxide dismutase
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in ng/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
vitamin e
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
selenium
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in ng/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
malondialdehyde
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in umol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
non coding RNA
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in copies/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
micro RNA
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in copies/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Lnc RNA
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in copies/mL
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
trimethylamine-N-oxide (TMAO)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in umol/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
phenylacetylglutamine (PAG)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in uM (micrometers)
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Comparing urine albumin-to-creatinine ratio (UACR)
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in mg/g
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Comparing salivary nitrite level as a correlate of plasma nitric oxide (NO) level
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in micromoles/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Comparing salivary nitrate level in as a correlate of plasma nitric oxide (NO) level
Description
Comparing it at both time points by dietary pattern and compared to its respective baseline in micromoles/L
Time Frame
Time zero (Visit 2, ~1-21 days after screen), at ~24 hours after time zero (Visit 3), at ~48 hours after time zero (Visit 4), after 8-12 day washout (Visit 5), at ~24 hours after 8-12 day washout (Visit 6), at ~48 hours after 8-12 day washout (Visit 7)
Title
Percent of time ≥50% erect during overnight sleep after 4 meals.
Description
Total time (in minutes) when penile rigidity is ≥50% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).
Time Frame
During overnight sleep directly after consuming the 4 meals.
Title
Percent of time ≥50% erect during overnight sleep after 1 meal.
Description
Total time (in minutes) when penile rigidity is ≥50% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).
Time Frame
During overnight sleep directly after consuming the 1 meal.
Title
Erection events per hour during overnight sleep after 1 meal.
Description
Total number of erection events lasting ≥5 minutes and with ≥70% rigidity at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™). This result will be reported as Events/hour.
Time Frame
During overnight sleep directly after consuming the 1 meal.
Title
Tumescence events per hour during overnight sleep after 1 meal.
Description
Total number of tumescence events lasting ≥5 minutes and when penile circumference increases by ≥2cm at both the tip and the base of the penis compared to their respective baselines as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™). This result will be reported as Tumescence events/hour.
Time Frame
During overnight sleep directly after consuming the 1 meal.
Title
Percent of time ≥70% erect during overnight sleep after 4 meals versus after 1 meal by dietary pattern.
Description
This outcome will evaluate whether a difference is present in the percent of time ≥70% erect during overnight sleep (as defined in outcomes above) directly after consuming the 4 meals versus directly after consuming the 1 meal by dietary pattern, for each dietary pattern. (e.g. is there a greater percentage of time ≥70% erect on the second night versus the first night when consuming the plant-based diet?).
Time Frame
During overnight sleep directly after consuming the 4 meals versus overnight sleep directly after consuming the 1 meal by dietary pattern, for each dietary pattern.
Title
Percent of time ≥50% erect during overnight sleep after 4 meals versus after 1 meal by dietary pattern.
Description
This outcome will evaluate whether a difference is present in the percent of time ≥50% erect during overnight sleep (as defined in outcomes above) directly after consuming the 4 meals versus directly after consuming the 1 meal by dietary pattern, for each dietary pattern. (e.g. is there a greater percentage of time ≥50% erect on the second night versus the first night when consuming the plant-based diet?).
Time Frame
During overnight sleep directly after consuming the 4 meals versus overnight sleep directly after consuming the 1 meal by dietary pattern, for each dietary pattern.
Title
Tumescence events per hour during overnight sleep after 4 meals versus after 1 meal by dietary pattern.
Description
This outcome will evaluate whether a difference is present in the total number of tumescence events per hour (as defined in outcomes above) directly after consuming the 4 meals versus directly after consuming the 1 meal by dietary pattern, for each dietary pattern. (e.g. is there a greater of tumescence events per hour on the second night versus the first night when consuming the plant-based diet?).
Time Frame
During overnight sleep directly after consuming the 4 meals versus overnight sleep directly after consuming the 1 meal by dietary pattern, for each dietary pattern.

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Subject provides written informed consent and HIPAA authorization in English before any study procedures are conducted. Subject is taking no medical therapy other than: prn MDIs, medication(s) for anxiety, depression, and/or ADHD (these medications include, but are not limited to, SSRIs, SNRIs, Stimulants), no change in supplements if applicable. The anxiety, depression, and/or ADHD will have been controlled (per report of subject) for the last 6 months. IIEF score greater or equal to 22 Subject will have had penile-sexual intercourse (either vaginal or anal penetration) within 12 weeks of enrollment. Male aged 18-35 years old Lives within commuting distance of Montefiore Health System Subject's significant other (if applicable) agrees to support the subject during the study Subject agrees to photograph and share all items consumed/drunk during the dietary intervention Subject agrees to avoid all illicit drugs, NSAIDS, and alcohol for at least two days prior to Rigiscan™ recording and on the days and nights of Rigiscan™ recording Subject agrees to refrain from sexual activity for at least 24 hours prior to Rigiscan™ placement and to have no sexual activity on the days and nights of Rigiscan™ recording. Subject agrees to not view, read, or otherwise consume erotic or pornographic material for 24 hours prior to both the days and nights of Rigiscan™ recording and on the days and nights of Rigiscan™ recording. Subject agrees to not have an orgasm for 24 hours prior to both the days and nights of RigiscanTM recording and on the days and nights of Rigiscan™ recording. Subject agrees to come to Montefiore to undergo Rigiscan™ training Subject agrees to only consume/drink permitted food/beverages. Subject agrees to attend all in person visits at Montefiore, to begin fasting at 11pm the night before each visit, and to undergo all blood draws/salivary/other testing. Subject agrees to not use mouthwash or mouth rinses or intentionally spit for the entire duration of the study. Subjects will be asked to refrain from using mouthwash for at least 2 days prior to enrollment. Subject agrees to not brush his teeth in the morning of the day of each study visit. Tooth brushing is otherwise permissible. BMI <30, BMI >=18.5, weight >110 lbs. Subject agrees to comply with the study procedures and visits. Subject exercises for at least 15 minutes at least two times per week If exercise is done, subjects will exercise for the same amount of time and at a similar intensity each day of Rigiscan™ testing. Otherwise, no exercise will be performed on Rigiscan™ days. If enrolled, subjects agree to not modify their dietary habits throughout the duration of the study other than during the two evenings and two full days when food is provided. Exclusion Criteria: Relevant dietary allergy Vegetarian or Vegan dietary pattern History of an eating disorder and/or food addiction Hypertension and or history of hypertension with or without medical treatment. Systolic blood pressure > 150mmHg and/or diastolic blood pressure >100mmHg on Visit one. Heart rate >99 on Visit one. Systolic blood pressure < 85mmHg and/or diastolic blood pressure < 50mmHg on Visit one. Heart rate < 35 on Visit one. BMI >=30, BMI <18.5, or weight <= 110lbs Known chronic medical disease other than non-inflammatory musculoskeletal disease, asthma, anxiety, depression, and/or ADHD. Subjects who have had changes in the dosage or type of their medication(s) for anxiety, depression, and/or ADHD within 3 months of enrollment. Subjects who have scheduled or planned medication and/or medication dose changes during the study period. These medication changes include the initiation of a new medication, discontinuation of a medication, modification of medication dose, and/or the route of administration of a medication. Subjects who are taking benzodiazepines and/or beta blockers History of kidney disease or hyperkalemia Subject has received an investigational drug within 30 days prior to signing consent Erectile dysfunction Has any condition (e.g., psychiatric illness) or situation that, in the investigator's opinion, may confound the study results, or may interfere significantly with the patient's ability to adhere with study procedures Currently undergoing treatment for Peyronie's Disease Abnormal Testosterone or Thyroid Stimulating Hormone level Treated hypogonadism or hypothyroidism Planned travel during the study The subject is trans-gender History of substance abuse in the last 12 months Illicit drug use, smoking, or vaping within 4 weeks Upper respiratory illness within two weeks on screening If profession requires being on call, no overnight or on call duties during the study Subject reports any communicable skin or venereal disease Subject reports rash or lesion on the penis or surrounding area. STOP-Bang score > 2 Having the diagnosis of Restless Leg Syndrome. Having insomnia as defined by: Subject with insomnia would have difficulty initiating or maintaining sleep (30 minutes or more at sleep initiation or 30 minutes or more to fall back asleep if wakes during the night). The above occurs at least 3 times per week for at least 1 month. Furthermore, there must be adequate opportunity for sleep and there must be associated morbidity (feels tired during the day). Definition based on: The International Classification of Sleep Disorders - Third Edition (ICSD-3), 2014.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Robert Ostfeld, MD
Phone
718-920-5197
Email
ROSTFELD@montefiore.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Ostfeld, MD
Organizational Affiliation
Montefiore Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montefiore Medical Center, Department of Medicine, Division of Cardiology
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert J Ostfeld, MD, MS
Phone
718-920-8011
Email
rostfeld@montefiore.org

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Impact of Dietary Pattern on Erectile Function

We'll reach out to this number within 24 hrs